Alexion

Alexion Pharma quarterly adj profit beats, raises forecast again
Yahoo/Reuters
Thu, 10/23/14 - 09:38 am
Alexion
earnings
Biogen Leads 5 Top Biotech Stocks As Earnings Loom
Investors.com
Tue, 10/21/14 - 09:55 pm
Biogen Idec
earnings
Celgene
Alexion
Regeneron
Gilead Sciences
The top 10 most expensive drugs of 2013
Fierce Pharma
Tue, 10/14/14 - 10:05 am
drug pricing
Soliris
Alexion
Naglazyme
Biomarin
Kalydeco
Vertex
Cinryze
Shire
Sprycel
Bristol-Myers Squibb
Pomalyst
Celgene
Xyrem
Jazz Pharmaceuticals
Erbitux
Merck KGaA
Revlimid
Questcor
Mallinckrodt
H.P. Acthar Gel
Biopharmaceutical companies are now increasingly relocating patent rights to overseas markets to lower their tax burden
Bidness Etc.
Wed, 10/1/14 - 08:09 am
tax inversions
intellectual property
Gilead Sciences
Alexion
5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential
24/7 Wall St
Thu, 09/25/14 - 09:21 am
orphan drugs
Alnylam
Biomarin
Alexion
Isis Pharmaceuticals
Vertex Pharmaceuticals
Alexion is Tagged by the FDA for Production Problems – Again
WSJ Pharmalot
Tue, 08/26/14 - 10:25 pm
FDA
drug manufacturing
Alexion
Jazz, Celgene Lead Top 4 Drugmaker Profit Margins
Investors.com
Mon, 08/18/14 - 04:21 pm
earnings
Jazz Pharmaceuticals
Celgene
Alexion
Regeneron
Alexion CEO Receives Nearly $17 Million for Sale of Company Stock
Yahoo/Gurufocus
Fri, 08/15/14 - 05:22 am
Alexion
Pharma CEOs
asfotase alfa
Top Biotech Earnings Previews for the Week Ahead
24/7 Wall St
Mon, 07/21/14 - 09:20 am
earnings
Cubist Pharma
Gilead Sciences
Biogen Idec
Celgene
Illumina
Alexion
Alexion Pharma Looks To Life Beyond Its Blockbuster
Investors.com
Tue, 07/8/14 - 04:52 pm
Alexion
Soliris
4 Biotech Stocks Worth A Look Ahead Of FDA Approvals
Yahoo/Benzinga
Thu, 07/3/14 - 12:07 pm
FDA
drug approvals
Acadia
Alexion
InterMune
Merrimack Pharmaceuticals
Soliris
pimavanserin
MM-398
Esbriet
The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher
24/7 Wall St
Wed, 07/2/14 - 11:49 am
Alexion
InterMune
FDA
Acadia
Kythera
Intercept Pharmaceuticals
Merrimack Pharmaceuticals
Relypsa
MM-398
patiromer
Esbriet
ATX-101
Soliris
Flint
pimavanserin
Alexion Posts Strong Earnings in Q1
Yahoo/Zacks.com
Thu, 04/24/14 - 05:58 pm
Alexion
earnings
Large Cap Biopharmaceuticals Are Core Holdings After Sell-Off: AbbVie, Amgen, Gilead
Seeking Alpha
Wed, 03/26/14 - 08:30 am
AbbVie
Amgen
Gilead Sciences
Achillion
Alexion
Ariad Pharmaceuticals
Pharmacyclics
Seattle Genetics
Time to Focus on Alexion (ALXN) for Strong Earnings Growth Potential
Yahoo/Zacks.com
Wed, 03/26/14 - 08:04 am
earnings
Alexion
Alexion to book additional Soliris sales, raises outlook
Reuters
Mon, 03/10/14 - 08:37 am
Alexion
Soliris
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data
Yahoo/Zacks.com
Wed, 03/5/14 - 11:46 am
InterMune
Esbriet
Alexion
Soliris
Vivus
Qsymia
Regeneron
Eylea
Alexion’s $569,000 Drug Draws Data Demand From U.K. NICE
Bloomberg
Mon, 03/3/14 - 09:10 pm
Alexion
NICE
Soliris
Is NPS Pharmaceuticals The Next Alexion?
Seeking Alpha
Tue, 02/25/14 - 11:03 am
NPS Pharmaceuticals
Alexion
NPSP795
Gattex
Biotech Stock Roundup: Strong Show from Biogen & Alexion; Medivation PREVAILs
Yahoo/Zacks.com
Wed, 02/5/14 - 09:40 am
Biogen Idec
Alexion
Medivation
Xtandi

Pages